Pulmonary Arterial Hypertension (PAH) Resources

Below we've gathered links to PAH organizations and community groups.

Links to other useful websites:

United Therapeutics Resources

Living PAH
A comprehensive program that can help you learn about PAH and your therapy options, while providing emotional support and an opportunity to talk with others who have been down a similar path.

Other Resources

Pulmonary Hypertension Association (PHA)
PHA's mission is to find ways to prevent and cure pulmonary hypertension, and to provide hope for the pulmonary hypertension community through support, education, advocacy, and awareness.

National Heart Lung and Blood Institute (NHLBI)
The NHLBI provides global leadership for a research, training, and education program to promote the prevention and treatment of heart, lung, and blood diseases, and to enhance the health of all individuals so they can live longer and more fulfilling lives.

Adult Congenital Heart Association (ACHA)
ACHA is a nonprofit organization seeking to improve the quality of life and extend the lives of people with congenital heart defects through education, outreach, advocacy, and promotion of research.

Indication

Adcirca is a prescription medication used to treat pulmonary arterial hypertension (WHO Group 1) to improve exercise ability. Studies establishing effectiveness included predominately patients with NYHA Functional Class II–III symptoms and etiologies of idiopathic or heritable PAH (61%) or PAH associated with connective tissue diseases (23%).

Important Safety Information for Adcirca

You should discuss all of your medical conditions and all medications with your doctor before starting Adcirca.

Do not take Adcirca if you take any medications that contain nitrates (often used for chest pain), as the combination could cause a sudden, unsafe drop in blood pressure.

Do not take Adcirca if you are allergic to tadalafil or any other ingredient in Adcirca.

If you experience chest pain after taking Adcirca, contact your doctor.

Adcirca is a type of medication called a PDE-5 inhibitor. Adcirca contains the same ingredient (tadalafil) as Cialis, which is used to treat erectile dysfunction (impotence). If you are taking Adcirca, do not take Cialis or other PDE-5 inhibitors.

PDE-5 inhibitors can cause blood vessels to widen, which may result in a decrease in blood pressure. If you have heart-disease or any problems with low blood pressure, tell your doctor before taking Adcirca, as these conditions may be affected by the action of Adcirca. If you have ever had blockage in the veins of your lungs, known as pulmonary veno-occlusive disease (PVOD), Adcirca is not recommended for you.

Do not take Adcirca if you are taking rifampin (an antibiotic for certain bacterial infections), or antifungal medications, such as ketoconazole and itraconazole. If you require treatment with both Adcirca and ritonavir (Norvir) at the same time, your dose of Adcirca will need to be adjusted. Taking Adcirca with alcohol, or blood pressure medications, such as alpha-blockers, may lower blood pressure and cause hypotension (fainting). Inform your doctor if you have kidney or liver problems before taking Adcirca.

In rare cases, men taking PDE-5 inhibitors (including tadalafil) for erectile dysfunction reported side effects such as a sudden decrease or loss of vision or hearing, or an erection lasting more than four hours. If you experience any of these side effects, seek medical attention right away.

The most common side effects of Adcirca are headache, muscle pain, getting red or hot in the face (flushing), nausea, pain in the arms, legs or back, upset stomach, stuffy or congested nose.

Click here for Full Prescribing Information and Patient Information or call 1-800-545-5979.

Close Window

Leaving Adcirca.com

You have just clicked on a link that will take you outside the Adcirca website. United Therapeutics Corporation does not monitor, does not imply any endorsement, and is not responsible for the content on outside websites.


Click "OK" to proceed to this third-party website or "CANCEL" to return to Adcirca.com.


Close WindowClose Window
Close Window

Leaving Adcirca.com and going to the United Therapeutics Corporation website

You have just clicked on a link that will take you to the United Therapeutics Corporation website (Unither.com), which has information about Adcirca, as well as other medications.


Click "OK" to proceed to the Unither.com website or "CANCEL" to return to Adcirca.com.


Close WindowClose Window
Close Window

Leaving Adcirca.com and Going to the Living PAH Website

You have just clicked on a link that will take you outside the Adcirca website to the Living PAH website.


Click "OK" to proceed to the Unither.com website or "CANCEL" to return to Adcirca.com.


Close WindowClose Window
Close Window

Thank You for Registering!

If you would like to learn more about United Therapeutics Corporation, visit www.unither.com.


Close Window

Duplicate e-mail

The database has detected that you've already registered with this e-mail address. You do not need to register for updates again. Thank you for your interest in Adcirca!


Close Window

Functional Classifications of PAH

This classification was created by the New York Heart Association (NYHA) to measure the degree of disease severity in patients with PAH. The World Health Organization (WHO) developed a similar functional class system that is also commonly used in assessing patients with PAH.


Close Window

Thank You for Sharing Your Story!

Your story will now be considered for posting on Adcirca.com. Please note that not all submitted stories will be posted. Thanks for your enthusiasm and support!


Close Window

Electronic Reprint System
Mobile™ ePrint

Hello,

Welcome to the electronic reprint system. Your Mobile™ ePrint is ready for download.

We recommend that you “Save” the file to your desktop for portability.

*** IMPORTANT NOTICE ***
This Mobile™ ePrint is ONLY supported on the PC platform. Mac users please click here for support.

To save your ePrint – Please follow these steps:

Step 1. To download the file, click on the Download File link provided below.

Step 2. To save the file to your desktop, click the “Save” button.

Step 3. Locate the file on your desktop and double click to open.

Download File - LWW_161918_CP.exe


How do I launch my Mobile™ ePrint for the first time?

Simply click on the “Download File” link that is embedded in this email. You will be prompted to either “Run” or “Save” the ePrint file. We recommend you save the ePrint file to a location on your computer where you can locate and activate it at a later time. To open the saved ePrint file simply double-click on the file icon you saved to your computer. You must be connected to the Internet the first time you open your ePrint. This one-time Internet connection allows your ePrint to validate itself.

Click here for more information.

Please email us at requestinfo@tsp.sheridan.com for any ePrint support questions.

Thank you for your order!